Scynexis (SCYX) Cash & Current Investments (2013 - 2026)
Scynexis (SCYX) reported Cash & Current Investments of $59.3 million for Q1 2026, up 703.35% on a YoY basis from $7.4 million in Q1 2025, and up 48.04% quarter-over-quarter from $40.0 million in Q4 2025.
Scynexis (SCYX) Cash & Current Investments (2013 - 2026) Analysis & Trends
Scynexis has reported Cash & Current Investments for 14 years, with the latest figure at $59.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 703.35% year-over-year to $59.3 million; the trailing twelve-month figure through Mar 2026 stood at $59.3 million (up 703.35% YoY), and the FY2025 full-year result was $40.0 million, up 142.82% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $59.3 million, up from $40.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $130.7 million in Q2 2024, with the low at $7.4 million in Q1 2025.
- Historically, Cash & Current Investments has averaged $70.6 million across 5 years, with a median of $73.5 million in 2022.
- Annual changes were most pronounced in 2025 — Cash & Current Investments plunged 92.2% — and 2026, when it jumped 703.35%.
- Scynexis' Cash & Current Investments stood at $73.5 million in 2022, then sank by 53.16% to $34.4 million in 2023, then tumbled by 52.12% to $16.5 million in 2024, then soared by 142.82% to $40.0 million in 2025, then surged by 48.04% to $59.3 million in 2026.
- The last three Cash & Current Investments figures came in at $59.3 million (Q1 2026), $40.0 million (Q4 2025), and $37.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Scynexis | 216.06 Mn | 156.80 Mn | - | 59.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.26 Mn |
| Dec 31, 2025 | 40.03 Mn |
| Sep 30, 2025 | 37.93 Mn |
| Jun 30, 2025 | 46.64 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 16.49 Mn |
| Sep 30, 2024 | 68.83 Mn |
| Jun 30, 2024 | 130.74 Mn |
| Mar 31, 2024 | 94.58 Mn |
| Dec 31, 2023 | 34.43 Mn |
| Sep 30, 2023 | 105.58 Mn |
| Jun 30, 2023 | 92.34 Mn |
| Mar 31, 2023 | 82.71 Mn |
| Dec 31, 2022 | 73.50 Mn |
| Sep 30, 2022 | 96.16 Mn |
| Jun 30, 2022 | 118.69 Mn |
| Mar 31, 2022 | 95.21 Mn |
| Dec 31, 2021 | 104.48 Mn |
| Sep 30, 2021 | 100.11 Mn |
| Jun 30, 2021 | 112.46 Mn |